Home | Technology News Search Engine:
|
|
|
Home: Technology News:
|
|
(IT-NEWSWIRE.COM, April 06, 2018 ) The global clinical genomics market will grow at a CAGR of 22.1% during the forecast period to reach USD 1,305.1 million by 2023, primarily driven by “growing significance of early disease detection and prevention, rising insistence for precision medicine, increasing application of genetic testing in oncology, and favourable reimbursement scenario related to genetic testing”, Meticulous Research™ noted in a press release today.
The global clinical genomics market is mainly segmented by test type (diagnostic testing, genetic testing, newborn screening, prenatal testing, preimplantation testing, carrier screening and other tests), software, method (molecular tests, chromosomal tests, biochemical tests), end user (hospitals & clinics, government laboratories & research centers, academics and research institutes and other end users), and geography.
The report notes that, based on methods the molecular tests held the largest share, owing to “the advancement in technology, which helps to detect the single nucleotide resolution with cheaper, faster, and with utmost accuracy by using WGS and WES technologies.”
Request Sample Report: https://tinyurl.com/y9tr52o3
Geographically, the global clinical genomics market is segmented into four major regions, namely North America, Europe, Asia-Pacific, and Rest of World. North America accounted for the major share of this market in 2017, followed by Europe and Asia-Pacific region. The major share of the North American region is mainly attributed to “the high burden of chronic and infectious diseases, increasing R&D expenditure, and various government initiatives”. However, the Asia-Pacific region is projected to grow at fastest CAGR during the forecast period, due to “increasing population, rising prevalence of various diseases, availability of funding, and developing healthcare infrastructures in the region”.
Browse report: https://tinyurl.com/y934m32o
The key players in the clinical genomics market are Quest Diagnostics Incorporated, Eurofins Scientific SE, Illumina, Inc., PerkinElmer, Inc., NeoGenomics Inc., Foundation Medicine, Inc., Rosetta Genomics Ltd., Invitae Corporation, Myriad Genetics, Inc., Natera, Inc., Genomic Health, Inc., OPKO Health, Inc., Centogene AG, Clinical Genomics Pty Ltd., 23andMe, Inc., Iverson Genetic Diagnostics, Inc., Veritas Genetics, Gene by Gene, Ltd., GenomeDx Biosciences, Inc., MedGenome, Strand Life Sciences Pvt. Ltd., Beijing Genomics Institute (BGI), Retrogen, Inc., Personalis, Inc., PathGroup.
Enquire before buying: https://tinyurl.com/ybwj4ojm
Key questions answered in the report-
Which are the high growth market segments in terms of test type, method, end user, and regions/countries?
What is the historical market for clinical genomics across the globe?
What are the market forecasts and estimates from the period 2016-2023?
What are the major drivers, restrains, opportunities, challenges and trends in the global clinical genomics market?
Who are the major players in the global clinical genomics market and what share of the market do they hold?
Who are the major players in various regions and what share of the market do they hold?
What are the competitive landscapes and who are the market leaders by sub-region in the global clinical genomics market?
What are the recent developments in the global clinical genomics market?
What are the different strategies adopted by the major players in the global clinical genomics market?
What are the geographical trends and high growth regions/countries?
What are the local emerging players in the global clinical genomics market and how do they compete with the global players?
Download PDF Brochure: https://tinyurl.com/y9nxo9r7
Meticulous Research™
chhagan yadav
+91 744-7780008
chhagan.y@meticulousresearch.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|
Technology News Headlines
|
|
|
Technology Business Video Feed
|
More Technology Video Feeds
|
|
|